Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 4, 2013, Pages 455-463

  Subramanian, V ^a,b   Johnston, R D ^a   Kaye, P ^a   Aithal, G P ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL FAT; ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARM FAT INDEX; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; DISEASE SEVERITY; FEMALE; GENDER; HIP CIRCUMFERENCE; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NAFLD ACTIVITY SCORE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SCORING SYSTEM; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

ADULT; ANTHROPOMETRY; BODY WEIGHTS AND MEASURES; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBCUTANEOUS FAT;

EID: 84872675170     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12198     Document Type: Article

References (38)

1. Angulo P,. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
2. Mohammed BS, Cohen S, Reeds D, Young VL, Klein S,. Long-term effects of large-volume liposuction on metabolic risk factors for coronary heart disease. Obesity (Silver Spring) 2008; 16: 2648-51.
3. Klein S, Fontana L, Young VL, et al,. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350: 2549-57.
4. Fan JG, Farrell GC,. VAT fat is bad for the liver, SAT fat is not! J Gastroenterol Hepatol 2008; 23: 829-32.
5. Guri AJ, Bassaganya-Riera J,. Systemic effects of white adipose tissue dysregulation and obesity-related inflammation. Obesity (Silver Spring) 2011; 19: 689-700.
6. Aithal GP, Thomas JA, Kaye PV, et al,. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008; 135: 1176-84.
7. Shadid S, Jensen MD,. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003; 26: 3148-52.
8. Han TS, Lean ME, Seidell JC,. Waist circumference remains useful predictor of coronary heart disease. BMJ 1996; 312: 1227-8.
9. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB,. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-63.
10. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K,. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007; 29: 115-28.
11. Hamdy O, Porramatikul S, Al-Ozairi E,. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-73.
12. Gambacciani M, Ciaponi M, Cappagli B, et al,. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997; 82: 414-7.
13. Nishizawa H, Shimomura I, Kishida K, et al,. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51: 2734-41.
14. Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P,. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005; 54: 1994-2002.
15. Arioglu E, Duncan-Morin J, Sebring N, et al,. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 2000; 133: 263-74.
16. Harries AD, Jones LA, Heatley RV, Newcombe RG, Rhodes J,. Precision of anthropometric measurements: the value of mid-arm circumference. Clin Nutr 1984; 2: 193-6.
17. Marks GC, Habicht JP, Mueller WH,. Reliability, dependability, and precision of anthropometric measurements. The Second National Health and Nutrition Examination Survey 1976-1980. Am J Epidemiol 1989; 130: 578-87.
18. de Alwis N, Aithal G, Bugianesi E, et al,. Mitochondrial DNA does not contribute to the heritability of non-alcoholic fatty liver disease. Mitochondrion 2011; 11: 234-5.
19. Kleiner DE, Brunt EM, Van Natta M, et al,. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
20. Frisancho A, ed. Anthropometric Standards for the Assessment of Growth and Nutritional Status. 1st edn. Ann Arbor, MI: Michigan University Press, 1990.
21. Frisancho AR,. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34: 2540-5.
22. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
23. Francque S, Verrijken A, Mertens I, et al,. Non-invasive assessment of non-alcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol 2012; 10: 1162-8.
24. Manco M, Bedogni G, Marcellini M, et al,. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 2008; 57: 1283-7.
25. Okorodudu DO, Jumean MF, Montori VM, et al,. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 2010; 34: 791-9.
26. Thomas EL, Saeed N, Hajnal JV, et al,. Magnetic resonance imaging of total body fat. J Appl Physiol 1998; 85: 1778-85.
27. van der Poorten D, Milner KL, Hui J, et al,. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48: 449-57.
28. Jun DW, Han JH, Kim SH, et al,. Association between low thigh fat and non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2008; 23: 888-93.
29. Suzuki A, Abdelmalek MF, Unalp-Arida A, et al,. Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol 2010; 8: 1062-9.
30. Ruhl CE, Everhart JE,. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology 2010; 138: 1346-56.
31. Petta S, Amato MC, Di Marco V, et al,. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012; 35: 238-47.
32. Perlemuter G, Naveau S, Belle-Croix F, et al,. Independent and opposite associations of trunk fat and leg fat with liver enzyme levels. Liver Int 2008; 28: 1381-8.
33. Cheung O, Kapoor A, Puri P, et al,. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology 2007; 46: 1091-100.
34. Nadas J, Putz Z, Kolev G, Nagy S, Jermendy G,. Intraobserver and interobserver variability of measuring waist circumference. Med Sci Monit 2008; 14: CR15-8.
35. Panoulas VF, Ahmad N, Fazal AA, et al,. The inter-operator variability in measuring waist circumference and its potential impact on the diagnosis of the metabolic syndrome. Postgrad Med J 2008; 84: 344-7.
36. Mason C, Katzmarzyk PT,. Effect of the site of measurement of waist circumference on the prevalence of the metabolic syndrome. Am J Cardiol 2009; 103: 1716-20.
37. Balkau B, Deanfield JE, Despres JP, et al,. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007; 116: 1942-51.
38. Fan JG, Peng YD,. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007; 6: 572-8.